The European market for Fluoroscopy was worth USD 532.91 million in 2021 and is estimated to be growing at a CAGR of 3.0% to reach USD 617.79 million by 2026. Fluoroscopy is the imaging innovation that utilizes an x-ray to acquire ongoing moving pictures of the inside of the body.
As per the 2017 European cardiovascular disease statistics, over the past two decades, the absolute number of CVD cases were increased in Europe, with the number of new CVD cases rising in most countries. In 2010, the incidence of cardiovascular disease was approximately 6.8 million. However, that number has grown to over 8.7 million by 2020. As cardiovascular disease increases in Europe, the demand for early diagnostic techniques such as fluoroscopy is expected to increase. It should help the market in the future. The European market is competitive because of the presence of almost all the global fluoroscopy market players. Many of these international players are based in European countries, increasing fluoroscopy devices' accessibility across Europe.
The European fluoroscopy market is anticipated to experience significant growth, with an elevating figure of high-precision minimally invasive surgeries, including the devices in utilization, emerging in better support for patients and surgeons. Rising prevalence for minimally invasive procedures is due to benefits, such as the lower risk of complications, lower cost and shorter recovery period, less pain, smaller incisions, and less scarring, contributing to market growth. The use of fluoroscopy in pain management is expected to complement the market growth.
However, the radiation risk from exposure to x-ray images is one of the significant factors limiting the growth of the Europe fluoroscopy equipment market. High exposure to ionizing radiation can increase the risk of cancer and radiation-induced burns. Besides, a shortage of medical professionals and a lack of awareness of innovative applications are other factors that are expected to hamper the Europe fluoroscopy equipment market's growth during the forecast period.
This research report on the Europe Fluoroscopy Market has been segmented and sub-segmented into the following categories:
Regional Analysis:
In Western Europe, in countries like the UK, Belgium, France, and Ireland, a significant amount of fluoroscopy equipment needs to be replaced. Simultaneously, the technology and digitization of fluoroscopy equipment will have a strong influence on purchasing mechanisms. Due to stricter radiation dose regulations, providers are adapting equipment to meet new standards, while at the same time building hybrid fluoroscopy and radiography to attract healthcare facilities. Due to changes in radiation dose regulations, fluoroscopy procedures are expected to receive established reimbursements. Therefore, more market participants are expected to launch products in this segment and exhibit various clinical applications, and hence the competitive scene in Western Europe is expected to increase.
Key market participants dominating the European Fluoroscopy market profiled in this report are Philips Healthcare, GE Healthcare, Siemens Medical Solutions, Shimadzu Medical Systems, Shanghai Bojin Medical Instrument Co., Ltd, and Toshiba Medical Systems Corp.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Fixed systems
5.1.3 Bio systems
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
5.2 Application 5.2.1 Introduction
5.2.2 Biopsy
5.2.3 Cardiovascularmediations
5.2.4 Orthopedic surgeries
5.3.5 Other Applications
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.3 End User 5.3.1 Introduction
5.3.2 Clinics
5.3.3 Hospitals
5.3.4 Diagnostic centers
5.4.7 Y-o-Y Growth Analysis, By End Users
5.4.8 Market Attractiveness Analysis, By End Users
5.4.9 Market Share Analysis, By End Users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis 6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis 6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Application
6.1.5.4 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Orthoscan Inc
8.3Hologic Inc
8.4 Shimadzu Corporation
8.5 Siemens Medical Solutions
8.6 Philips N.V
8.7 Hitachi Ltd
8.8 Toshiba Medical Systems Corporation
8.9 Ziehm Imaging GmbH
8.10 Amico X-ray innovations
8.11 Carestream Health
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
